COMMENTARY

• Cell Therapy Makers Working to Stand Out from Rivals by Reducing Burdens on Hospitals
  April 16, 2019

• Building Credible, Convincing System Holds Key for Japan’s Cost-Effectiveness Assessment
  April 2, 2019

• Generic Makers Shifting to Focus on “Specialty Area” Faced with Tougher Business Environment
  March 4, 2019

• Restructuring, Divestment Progress in Wake of Drug Pricing Overhaul
  February 20, 2019

• 2019 Likely to Herald Burst of “Regenerative Medicine” Approvals
  January 11, 2019

• LDP Draws Up Tax Reform Outline, Revamps Credits for R&D Expenses
  December 17, 2018

• After Thumbs-Up Given to Shire Buy, Weber’s Leadership Will Now Be Put to Test
  December 12, 2018

• Does Dissolution of Japan Vaccine Signal Demise of Model in Vaccine Industry Vision, or Will a Second Round of JV Take Place?
  November 27, 2018

• There’s Room for Growth in Biosimilar Space, but Who Will Grab It?
  August 3, 2018

• Astellas/Daiichi Sankyo Showdown Looms as Their FLT3 Inhibitors Near Approval
  July 12, 2018

• LDP Heavyweights on Guard for Push to Scrap Coverage for Patch Medications
  July 5, 2018

• Kudos to MHLW for Creating New Confab, but 1st Meeting Stirs Industry Frustration
  May 30, 2018

• Japan Trains Sight on CEA as Centerpiece of This Year’s Cost Containment Efforts
  April 23, 2018

• With Drug Price Cuts Done, MHLW Now Running Ministry-Wide Initiative to Shave Prescriptions
  April 4, 2018

• Will Drug Makers Move to Pull Plug on Off-Patent Brands under “G1” Scheme?
  March 12, 2018

• With CiCLE Program Entering 2nd Year, AMED Should Release More Information on Grant Program
  February 28, 2018

• Chuikyo Moving toward Conclusion on Issue of Insurance Coverage for Heparinoid Drugs
  January 15, 2018

• Pricing Reform Could Goad Drug Makers to Focus Resources on PMP Hopefuls
  December 28, 2017

• Unraveling MHLW/MOF Tug-of-War on Drug Pricing Reform
  November 8, 2017

• With Study Group on Counterfeit Drugs to Resume Discussions this Fall, Full-Scale Discussions on Introduction of PIC/S GDP Guidelines Looming
  October 10, 2017

ページ